Global OrganonChips Market By Organ Overview
Introduction:
Organ-on-a-chip is an advanced technology which helps to produce human organ systems in miniature on micro-engineered chips that are about the size of an AA battery. This innovative technology help scientists to achieve a better understanding of the effects of medicines, disease-causing bacteria in chemicals, food, and other potentially harmful materials on the human body.
Drivers and Restraints:
The requirement of alternative for animal testing is the major propelling factor for the growth of the global market. For instance, as per the US department of agriculture around 750,000 animals were used in the experiment to know the effect of organ-on-chip on the human body. Additionally, there is a need for early detection of the drug toxicity which is another driving factor for the growth of the target market. Moreover, the launch of new products and advancement in technology is the boosting factor for the growth of the global market. However, the complexity in producing architectural tissues and organs is the major restraining factor for the growth of the global market. Nevertheless, the increase in funding and research and development activities can create an opportunity for the development of the target market.
Segmentation:
The global organ-on-chip market is segmented based on organ type, application, end-user, and region.
Based on organ type, the global organ-on-chips market is segmented into the liver, heart, lung, and other organ types. Based on the application, the global market is classified into drug discovery, toxicology research, and other applications. Based on end-user, the target market is segmented into pharmaceutical and biotechnology companies, academic and research institutes, and other end users.
On the region, the global organ-on-chips market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The North America region is the dominating region in the global organ-on-chip market due to the increasing number of heart failure patients. Europe is expected to show significant growth for the development of the target market during the forecast period due to increasing organ failure cases and advancement in the technology.
Key Players:
The key players operating the global organ-on-chips market includes AxoSim Inc., BiomimX SRL, Elveflow, Emulate Inc., Hurel Corporation, InSphero AG, MIMETAS BV, Nortis Inc., Tara Biosystems, and TissUse GmbH. Prominent players operating in the target market are focusing on strategic partnerships as well as the launching of the organ types to gain a competitive edge in the target market. For instance, in 2018, AstraZeneca and Emulate Inc. declared a strategic agreement to work on organs-on-chips technology to enhance prediction of human safety and efficacy of drug candidates.
Detailed Segmentation:
Global Organ-on-Chips Market, By Organ Type:
- Liver
- Heart
- Lungs
- Other Organ Types
Global Organ-on-Chips Market, By Application:
- Drug Discovery
- Toxicology Research
- Other Applications
Global Organ-on-Chips Market, By End-user:
- Pharmaceutical and Biotechnology Companies
- Academic and Research Institutes
- Other End Users
Global Organ-on-Chips Market, By Region:
-
-
- North America
- North America Organ-on-Chips Market, By Organ Type
- North America Organ-on-Chips Market, By Application
- North America Organ-on-Chips Market, By End-user
- North America Organ-on-Chips Market, By Country
- U.S.
- Canada
- Europe
- Europe Organ-on-Chips Market, By Organ Type
- Europe Organ-on-Chips Market, By Application
- Europe Organ-on-Chips Market, By End-user
- Europe Organ-on-Chips Market, By Country
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia Pacific
- Asia Pacific Organ-on-Chips Market, By Organ Type
- Asia Pacific Organ-on-Chips Market, By Application
- Asia Pacific Organ-on-Chips Market, By End-user
- Asia Pacific Organ-on-Chips Market, By Country
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
- Latin America
- Latin America Organ-on-Chips Market, By Organ Type
- Latin America Organ-on-Chips Market, By Application
- Latin America Organ-on-Chips Market, By End-user
- Latin America Organ-on-Chips Market, By Country
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- Middle East & Africa Organ-on-Chips Market, By Organ Type
- Middle East & Africa Organ-on-Chips Market, By Application
- Middle East & Africa Organ-on-Chips Market, By End-user
- Middle East & Africa Organ-on-Chips Market, By Country
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- North America
-
Company Profile:
- AxoSim Inc.
-
-
- Company Overview
-
-
-
-
-
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
-
-
- BiomimX SRL
- Elveflow
- Emulate Inc.
- Hurel Corporation
- InSphero AG
- MIMETAS BV
- Nortis Inc.
- Tara Biosystems
- TissUse GmbH
“*” marked represents similar segmentation in other categories in the respective section
Key Issues Addressed
- What is the total revenue potential of the global organ-on-chips market? How that market is expected to grow during the study period?
- What are the major growth opportunities in the organ-on-chips market?
- Which companies are the major players in the global organ-on-chips market?
FAQs
The organ-on-chips market accounted for the US $85.05Mn in 2024 and is also projected to register a moderate CAGR of 33.40% over the forecast period.
The market report has been segmented based on organ type, application, end-user, and region.
Emerging trends include the development of more complex and integrated organ-on-chip systems, the application of artificial intelligence in data analysis, and the increasing use of organ-on-chip technology in drug discovery and toxicity testing, presenting significant opportunities in the global Organ-on-Chips Market.
Factors driving the market include the need for more accurate and human-relevant models in drug development, advancements in microfabrication technologies, the potential for personalized medicine applications, and collaborations between academic research institutions and industry players.
The report covers regions worldwide. North America is expected to dominate the Organ-on-Chips Market, driven by a well-established life sciences sector, high research and development activities, and the presence of key market players in the region. Other influential regions include Europe and Asia-Pacific.
The prominent player operating in the global organ-on-chips market includes AxoSim Inc., BiomimX SRL, Elveflow, Emulate Inc., Hurel Corporation, InSphero AG, MIMETAS BV, Nortis Inc., Tara Biosystems, and TissUse GmbH